We use cookies on this website to enhance your user experience. Please read our cookie policy for additional information and a complete overview. We will only use cookies if you consent by clicking on “Accept all cookies”. You can always manage your preferences via the settings of your browser. Please note that certain media will only be available if you have accepted the applicable cookies.
De-risking CNS treatment development 25th of May – 6pm CEST
Session one: epilepsy treatment
We are very honored to invite top experts Prof. Eugen Trinka, Dr Neuray, Dr Komorowski, Dr Haubenberger
Final agenda
Optimal EEG use in treatment development by Prof. Eugen Trinka
Current evidence for EEG derived features as potential biomarkers by Dr Caroline Neuray
Real-world evidence sharing by Rob Komorowski (Biogen) and Dietrich Haubenberger (Neurocrine)
Bridging the gap by Epilog – Jurgen Van Broeck
Subscribe // natasja@epilog.care